cDNA microarray analysis of the gene expression profile of VEGF-activated human umbilical vein endothelial cells

Angiogenesis

Volumn 4, Issue 4, 2001, Pages 289-298

  Abe, Mayumi ^a   Sato, Yasufumi ^a  

^a TOHOKU UNIVERSITY   (Japan)

Author keywords

Angiogenesis; cDNA microarray; Endothelial cells; VEGF

Indexed keywords

ANGIOPOIETIN 2; CYCLOOXYGENASE 2; EARLY GROWTH RESPONSE FACTOR 1; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; PROLYLLEUCYLGLYCINAMIDE; VASCULOTROPIN;

ARTICLE; BLOOD VESSEL PERMEABILITY; CELL ACTIVATION; CONTROLLED STUDY; DNA MICROARRAY; DOWN SYNDROME; ENDOTHELIUM CELL; GENE EXPRESSION PROFILING; GENE SEQUENCE; HUMAN; HUMAN CELL; MOLECULAR BIOLOGY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; UMBILICAL VEIN; UNINDEXED SEQUENCE;

BASE SEQUENCE; DNA PRIMERS; DNA, COMPLEMENTARY; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; LYMPHOKINES; NEOVASCULARIZATION, PATHOLOGIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; UMBILICAL VEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0035745001     PISSN: 09696970     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1016018617152     Document Type: Article

References (43)

1. Vascular-specific growth factors and blood vessel formation
2. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization
3. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization
4. Origins of circulating endothelial cells and endothelial outgrowth from blood
5. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells
6. Mechanisms of angiogenesis
7. The biology of vascular endothelial growth factor
8. Roles of two VEGF receptors, Flt-1 and KDR, in the signal transduction of VEGF effects in human vascular endothelial cells
9. Properties of two VEGF receptors, Flt-1 and KDR, in signal transduction
10. Heterogeneity of the signal transduction pathways for VEGF-mediated MAPKs activation in human vascular endothelial cells
11. Vascular permeability factor: A tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration
12. VEGF increases retinal vascular ICAM-1 expression in vivo
13. Gene expression profiling in an in vitro model of angiogenesis
14. Genes expressed in human tumor endothelium
15. The gene expression profile of human umbilical vein endothelial cells stimulated by tumor necrosis factor alpha using DNA microarray analysis
16. Transcriptional profiling of human microvascular endothelial cells in the proliferative and quiescent state cDNA arrays
17. A Ras by any other name
18. Ras isoforms vary in their ability to activate Raf-1 and phosphoinositide 3-kinase
19. Four human ras homologs differ in their abilities to activate Raf-1, induce transformation, and stimulate cell motility
20. Fibroblast growth factor receptor-1-mediated endothelial cell proliferation is dependent on the Src homology (SH) 2/SH3 domain-containing adaptor protein Crk
21. Ets-1 regulates angiogenesis by inducing the expression of urokinase-type plasminogen activator and matrix metalloproteinase-I and the migration of vascular endothelial cells
22. Indispensable role of the transcription factor PEBP2/CBF in angiogenic activity of a murine endothelial cell MSS31
23. The contributions of cyclooxygenase-2 to tumor angiogenesis
24. Selective inhibition of vascular endothelial growth factor-mediated angiogenesis by cyclosporin A. Roles of the nuclear factor of activated T cells and cyclooxygenase 2
25. Vascular endothelial growth factor induces heparin-binding epidermal growth factorlike growth factor in vascular endothelial cells
26. Heparin-binding epidermal growth factor-like growth factor: p91 Activation induction of plasminogen activator/inhibitor, and tubular morphogenesis in human microvascular endothelial cells
27. Angiotensin AT(1) and AT(2) receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivation
28. Vascular endothelial cell growth factor-induced tissue factor expression in endothelial cells is mediated by EGR-1
29. Egr-1 mediates extracellular matrix-driven transcription of membrane type 1 matrix metalloproteinase in endothelium
30. Tissue repair with a therapeutic transcription factor
31. CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth
32. Mechanisms of angiogenesis and their use in the inhibition of tumor growth and metastasis
33. A identification of podocalyxin-like protein 1 as a novel cell surface marker for hemangioblasts in the murine aorta-gonad-mesonephros region
34. Bactericidal/permeability-increasing protein (BPI) inhibits angiogenesis via induction of apoptosis in vascular endothelial cells
35. Angiotensin II stimulates angiogenesis in the chorio-allantoic membrane of the chick embryo
36. Vascular endothelial growth factor is inactivated by binding to alpha 2-macroglobulin and the binding is inhibited by heparin
37. Thrombomodulin-dependent anticoagulant activity is regulated by vascular endothelial growth factor
38. The role of alphav integrins during angiogenesis: Insights into potential mechanisms of action and clinical development
39. A protein encoded within the Down syndrome critical region is enriched in striated muscles and inhibits calcineurin signaling
40. DSCR1, overexpressed in Down syndrome, is an inhibitor of calcineurin-mediated signaling pathways
41. Dscr1, a novel endogenous inhibitor of calcineurin signaling, is expressed in the primitive ventricle of the heart and during neurogenesis
42. The novel MMS-inducible gene Mif1/KIAA0025 is a target of the unfolded protein response pathway
43. Effect of rifampin on CDlb expression and double-negative T cell responses against mycobacteria-derived glycolipid antigen